InspireMD to Announce Third Quarter 2025 Financial Results
Rhea-AI Summary
InspireMD (Nasdaq: NSPR) announced it will release its third quarter 2025 financial results on Tuesday, November 4, 2025.
The company will host a conference call and webcast on November 4, 2025 at 8:30 a.m. Eastern Time to review results and recent highlights. Domestic callers may dial 1-800-579-2543; international callers may dial 1-785-424-1789. Investors can join the live webinar via InspireMD’s website or the provided webcast registration link. A replay will be available shortly after the call and archived on the company website.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, NSPR gained 0.43%, reflecting a mild positive market reaction. This price movement added approximately $400K to the company's valuation, bringing the market cap to $93M at that time.
Data tracked by StockTitan Argus on the day of publication.
MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for domestic callers or 1-785-424-1789 for international callers. The live webinar may be accessed by visiting InspireMD’s website or by registering below. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on InspireMD’s website.
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1738063&tp_key=c84683c4fd
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contact:
Webb Campbell
Gilmartin Group LLC
Webb@gilmartinir.com
investor-relations@inspiremd.com
FAQ
When will InspireMD (NSPR) release its third quarter 2025 financial results?
What time is the InspireMD (NSPR) Q3 2025 earnings call and webcast?
How can investors join the InspireMD (NSPR) earnings call by phone?
Where can I access the InspireMD (NSPR) live webinar and replay for Q3 2025?
Will the InspireMD (NSPR) earnings webcast be available after the live call?
